
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
Export 23 results:
Author Title [ Type
Filters: Author is Rodriguez, L. A. [Clear All Filters]
“Use of antidepressants and the risk of Parkinson's disease: a prospective study”, J Neurol Neurosurg Psychiatry, vol. 80, pp. 671-4, 2009.
, “Upper gastrointestinal complications among users of paracetamol”, Basic Clin Pharmacol Toxicol, vol. 98, pp. 297-303, 2006.
, “Steroids and risk of upper gastrointestinal complications”, Am J Epidemiol, vol. 153, pp. 1089-93, 2001.
, “Risk of ventricular arrhythmias associated with nonsedating antihistamine drugs”, Br J Clin Pharmacol, vol. 47, pp. 307-13, 1999.
, “Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism”, Thromb J, vol. 6, p. 10, 2008.
, “The risk of acute pancreatitis associated with acid-suppressing drugs”, Br J Clin Pharmacol, vol. 49, pp. 473-8, 2000.
, “Rheumatoid arthritis in UK primary care: incidence and prior morbidity”, Scand J Rheumatol, vol. 38, pp. 173-7, 2009.
, “A prospective study of alcoholism and the risk of Parkinson's disease”, J Neurol, vol. 251 Suppl 7, pp. vII14-7, 2004.
, “Lipid-lowering drugs and risk of myopathy: a population-based follow-up study”, Epidemiology, vol. 12, pp. 565-9, 2001.
, “Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link?”, Dig Dis Sci, vol. 54, pp. 1079-86, 2009.
, “Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study”, Bmj, vol. 318, pp. 565-6, 1999.
, “Incidence of ocular melanoma in the general population and in glaucoma patients”, J Epidemiol Community Health, vol. 55, pp. 338-9, 2001.
, “Incidence of chronic atrial fibrillation in general practice and its treatment pattern”, J Clin Epidemiol, vol. 55, pp. 358-63, 2002.
, “Incidence and risk factors for psoriasis in the general population”, Arch Dermatol, vol. 143, pp. 1559-65, 2007.
, “Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study”, Respir Med, vol. 104, pp. 1691-9, 2010.
, “Gout and risk of Parkinson disease: a prospective study”, Neurology, vol. 69, pp. 1696-700, 2007.
, “Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice”, Chest, vol. 128, pp. 85-93, 2005.
, “Frequency and risk factors of gout flares in a large population-based cohort of incident gout”, Rheumatology (Oxford), vol. 50, pp. 973-81, 2011.
, “Endoscopic findings in a cohort of newly diagnosed gastroesophageal reflux disease patients registered in a UK primary care database”, Dis Esophagus, vol. 20, pp. 504-9, 2007.
, “Chest pain in general practice: incidence, comorbidity and mortality”, Fam Pract, vol. 23, pp. 167-74, 2006.
, “Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study”, Bmj, vol. 319, pp. 1106-9, 1999.
, “Association between captopril, other antihypertensive drugs and risk of prostate cancer”, Prostate, vol. 58, pp. 50-6, 2004.
, “Ascertainment of acute liver injury in two European primary care databases”, Eur J Clin Pharmacol, vol. 70, pp. 1227-35, 2014.
,